Jia-Teh Liao

Title: Innovations of Jia-Teh Liao

Introduction

Jia-Teh Liao is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant viral constructs. His work focuses on enhancing the expression of exogenous polypeptides, which has important implications for immunization and therapeutic applications.

Latest Patents

Jia-Teh Liao holds a patent for "Recombinant flaviviral constructs and uses thereof." This innovative patent describes a recombinant viral construct derived from the Japanese encephalitis virus (JEV). The construct is designed to express an exogenous polypeptide within a cell, encoding a fusion protein that includes both the exogenous polypeptide and a segment of the JEV non-structural protein 1 (JEV NS1). The unique aspect of this invention is that the production of the recombinant fusion protein does not interfere with viral replication. Upon infection of a cell with these constructs, JEV particles can be produced, which are useful in eliciting an immune response and providing protective immunization against the exogenous polypeptide.

Career Highlights

Jia-Teh Liao is affiliated with the National Defensive Medical Center, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in vaccine development and therapeutic strategies against viral infections.

Collaborations

Jia-Teh Liao collaborates with Ching-Len Liao, contributing to the advancement of their shared research interests in viral constructs and immunology.

Conclusion

Jia-Teh Liao's innovative work in recombinant viral constructs represents a significant advancement in biotechnology. His contributions have the potential to enhance immunization strategies and improve public health outcomes.